| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/11/2009 | CA2706894A1 Biological systems for production of commercially valuable compounds |
| 06/10/2009 | EP2068147A1 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 06/10/2009 | EP2067857A1 Method for production of dipeptide |
| 06/10/2009 | EP2067854A1 Improved bacterial host cell for the direct expression of peptides |
| 06/10/2009 | EP2067792A2 Inhibitory antibodies of HER3 activity |
| 06/10/2009 | EP2067791A1 Prophylactic or therapeutic agent for cancer |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067788A2 Fab fragment libraries and methods for their use |
| 06/10/2009 | EP2067472A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/10/2009 | EP2066339A2 Compositions and methods of enhancing immune responses |
| 06/10/2009 | EP1129180B1 Chemically modified mutant serine hydrolases |
| 06/10/2009 | EP1007570B1 Monospecific antibody reactive with fibrinogen and fibrinopeptide b |
| 06/10/2009 | CN101454461A Methods and compositions comprising non-natural amino acids |
| 06/10/2009 | CN101451158A Separation and purification method of antibiotic peptides produced by Lactobacillus paracasei |
| 06/10/2009 | CN100497652C Method for preparing water soluble wheat protein by composite modification |
| 06/10/2009 | CN100497628C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 06/10/2009 | CN100497619C Shingolipid ceramide deacylase gene |
| 06/10/2009 | CN100497610C Polypeptides encoded by human lipase-like gene and composition, and methods of utilizing same |
| 06/10/2009 | CN100497601C Human myeloma cell line |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497379C Protein complex serving as vehicle for orally administerable medicaments |
| 06/10/2009 | CN100497369C Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 06/09/2009 | US7544853 C1 inhibitor with short half-life transient treatment |
| 06/09/2009 | US7544795 food products such as doughs and dairy products, animal feed, pharmaceuticals, cosmetics, dental care products; purity |
| 06/09/2009 | US7544790 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544783 Active constituent in antiallergic medicine; block the IgE acceptor; specifically bind to a native IgG inhibitory receptor containing immunoreceptor tyrosine-based inhibitory motif, thereby inhibiting the IgE-driven mediator release from mast cells and basophils |
| 06/09/2009 | US7544779 cysteine mutant proteins that bind to their cognate receptor or exhibit antiviral activity; polypeptides; fusion proteins |
| 06/09/2009 | US7544776 Long wavelength engineered fluorescent proteins |
| 06/09/2009 | US7544771 Identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases; purifying a biological sample and determining amount of protein biomarker |
| 06/09/2009 | US7544661 Micellular reaction product of a peptide and a growth factor recognition ligand for growth factors selected from bone morphogenic protein-2, TGF- beta 1, VEGF, FGF-2, nerve growth factor-3 and laminin-5 and made from mesenchymal stem cells; improved bioavailability |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544512 Transforming and fermenting gene products from cells comprising nucleotide sequences coding glucagon like polypeptides for use in stimulation and secretion of insulin; diabetes treatment; bioreactors |
| 06/09/2009 | US7544499 For treating an animal suffering from an excess of CHASEGP substrate produced from glial scar resulting from spinal cord injury or surgery; herniated disk; genetic engineering |
| 06/09/2009 | US7544493 Method for the purification of an N-terminal fragment of hepatocyte growth factor |
| 06/09/2009 | US7544490 Nucleic acid sequences encoding secretion-associated proteins; cells genetically manipulated to have an altered capacity to produce expressed proteins |
| 06/09/2009 | US7544489 Nucleic acid sequences encoding secretion-associated proteins; cells genetically manipulated to have an altered capacity to produce expressed proteins |
| 06/09/2009 | US7544488 Secretion, transcription and sporulation genes in Bacillus clausii |
| 06/09/2009 | US7544487 Fusion proteins containing recombinant cytotoxic RNAses |
| 06/09/2009 | US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders |
| 06/09/2009 | US7544485 Baldness related gene and the polypeptide encoded thereby, and uses |
| 06/09/2009 | US7544484 secretory or chimeric fusion protein is composed of Vargula luciferase and Yellow fluorescent protein, having an energy transfer property, energy-generating protein and an energy-receiving protein; fluorescent protein is excited with light emitted from the light-emitting enzyme; drug screening |
| 06/09/2009 | US7544483 Method for the production of protamine |
| 06/09/2009 | US7544482 Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| 06/09/2009 | US7544479 Method for identifying MLK inhibitors for treatment of neurological conditions |
| 06/09/2009 | US7544358 Bacterial sepsis, hemorrhagic shock, toxic inhalation, and bleomycin and other drug-induced lung injury; fibronectin and tenascin receptor antagonist; cancer |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/09/2009 | CA2269083C Novel fgf homologs |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/09/2009 | CA2199408C Herpes simplex virus glycoprotein d variants |
| 06/04/2009 | WO2009069381A1 Transformant transfected with flavin adenine dinucleotide-binding glucose dehydrogenase gene and method for producing flavin adenine dinucleotide-binding glucose dehydrogenase using the same |
| 06/04/2009 | WO2009069355A1 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 06/04/2009 | WO2009052489A3 Novel inhibitors of mammalian tight junction opening |
| 06/04/2009 | WO2009051957A3 Antibodies to irem-1 |
| 06/04/2009 | WO2007044731A3 Recombinant proteins from filoviruses and their use |
| 06/04/2009 | WO2007009065A3 Methods of treating autoimmune disease using humanized anti-cd16a antibodies |
| 06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
| 06/04/2009 | US20090144852 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 06/04/2009 | US20090144849 Nucleic acid molecules and other molecules associated with transcription in plants |
| 06/04/2009 | US20090144841 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications |
| 06/04/2009 | US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 06/04/2009 | US20090143569 Bacteriolytic agent |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143529 Peptide purification by means of hard metal ion affinity chromatography |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090143288 Peptide-complement conjugates |
| 06/04/2009 | US20090143248 Biologically active C-terminal arginine-containing peptides |
| 06/04/2009 | US20090142855 Polynucleotides and Polypeptides of the IL-12 Family of Cytokines |
| 06/04/2009 | US20090142851 Method for selectively recovering c-terminal peptide of protein and method for determining amino acid sequence of c-terminal peptide of protein using the same |
| 06/04/2009 | US20090142841 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 06/04/2009 | US20090142838 Methods for expressing rnp particles in eukaryotic cells |
| 06/04/2009 | US20090142808 Novel enzyme with fructofuranosidase activity, which is used to obtain prebiotic oligosaccharides |
| 06/04/2009 | US20090142807 rabbit-derived immortal B-lymphocyte capable of fusion with a rabbit splenocyte to produce a hybrid cell that produces an antibody; hybridoma produced as a result of the fusion |
| 06/04/2009 | US20090142806 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 06/04/2009 | US20090142805 High expression cell line that eliminates gene amplification |
| 06/04/2009 | US20090142804 Process For Preparing Serine-Rich Protein Employing Cysteine Synthase (CYSK) Gene |
| 06/04/2009 | US20090142803 Amylolytic Enzyme Variants |
| 06/04/2009 | US20090142802 Polypeptides and nucleic acids encoding same |
| 06/04/2009 | US20090142801 butyrophilin-like nucleic acids; for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen |
| 06/04/2009 | US20090142800 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/04/2009 | US20090142787 denaturing, digesting via protease; adding metalloprotease into sample, quaternary ammonium compound, fructosyl amino acid oxidase, measuring redox reaction procuct |
| 06/04/2009 | US20090142786 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142429 Silicibacter sp. strain useful for genetic transformation of marine algae and production of antibiotic agents |
| 06/04/2009 | US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof |
| 06/04/2009 | US20090142359 Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells; treating cancer by Her2 overexpression using the antibodies |
| 06/04/2009 | US20090142352 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 06/04/2009 | US20090142349 CD19 Antibodies And Their uses |
| 06/04/2009 | US20090142343 Anti-VEGF antibodies |
| 06/04/2009 | US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142326 Glycosidase Enzymes |
| 06/04/2009 | US20090142261 EPHB3-Specific Antibody and Uses Thereof |
| 06/04/2009 | CA2706560A1 Differentiation of human embryonic stem cells |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |